Open Access
Open access
Elsevier
JAAD International
,  volume 17 ,  pages 71-79

The role of IL-17 and IL-23 inhibitors in the development, progression, and recurrence of cancer: a systematic review

Marie Vangilbergen 1
, 
Aline Stockman 2
, 
Axelle Van De Velde 2
, 
Maria Garmyn 1, 3
, 
Kevin Punie 4
, 
Tom Hillary 1
1
 
2
 
3
 
4
 
Department of Medical Oncology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium | 
Publication type: Journal Article
Publication date: 2024-12-01
Elsevier
scimago Q1
wos Q1
SJR: 0.896
CiteScore: 4.3
Impact factor: 5.2
ISSN: 26663287
Found 
Found 

Top-30

Journals

1
Cancers
Cancers, 1, 11.11%
Cancers
1 publication, 11.11%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 11.11%
International Journal of Molecular Sciences
1 publication, 11.11%
Carcinogenesis
Carcinogenesis, 1, 11.11%
Carcinogenesis
1 publication, 11.11%
Archives of Dermatological Research
Archives of Dermatological Research, 1, 11.11%
Archives of Dermatological Research
1 publication, 11.11%
Cureus
Cureus, 1, 11.11%
Cureus
1 publication, 11.11%
Frontiers in Immunology
Frontiers in Immunology, 1, 11.11%
Frontiers in Immunology
1 publication, 11.11%
Journal of Dermatological Treatment
Journal of Dermatological Treatment, 1, 11.11%
Journal of Dermatological Treatment
1 publication, 11.11%
1

Publishers

1
2
MDPI
MDPI, 2, 22.22%
MDPI
2 publications, 22.22%
Springer Nature
Springer Nature, 2, 22.22%
Springer Nature
2 publications, 22.22%
Oxford University Press
Oxford University Press, 1, 11.11%
Oxford University Press
1 publication, 11.11%
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory, 1, 11.11%
Cold Spring Harbor Laboratory
1 publication, 11.11%
IntechOpen, 1, 11.11%
IntechOpen
1 publication, 11.11%
Frontiers Media S.A.
Frontiers Media S.A., 1, 11.11%
Frontiers Media S.A.
1 publication, 11.11%
Taylor & Francis
Taylor & Francis, 1, 11.11%
Taylor & Francis
1 publication, 11.11%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
9
Share
Cite this
GOST |
Cite this
GOST Copy
Vangilbergen M. et al. The role of IL-17 and IL-23 inhibitors in the development, progression, and recurrence of cancer: a systematic review // JAAD International. 2024. Vol. 17. pp. 71-79.
GOST all authors (up to 50) Copy
Vangilbergen M., Stockman A., Van De Velde A., Garmyn M., Punie K., Hillary T. The role of IL-17 and IL-23 inhibitors in the development, progression, and recurrence of cancer: a systematic review // JAAD International. 2024. Vol. 17. pp. 71-79.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.jdin.2024.06.006
UR - https://linkinghub.elsevier.com/retrieve/pii/S266632872400110X
TI - The role of IL-17 and IL-23 inhibitors in the development, progression, and recurrence of cancer: a systematic review
T2 - JAAD International
AU - Vangilbergen, Marie
AU - Stockman, Aline
AU - Van De Velde, Axelle
AU - Garmyn, Maria
AU - Punie, Kevin
AU - Hillary, Tom
PY - 2024
DA - 2024/12/01
PB - Elsevier
SP - 71-79
VL - 17
PMID - 39411241
SN - 2666-3287
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Vangilbergen,
author = {Marie Vangilbergen and Aline Stockman and Axelle Van De Velde and Maria Garmyn and Kevin Punie and Tom Hillary},
title = {The role of IL-17 and IL-23 inhibitors in the development, progression, and recurrence of cancer: a systematic review},
journal = {JAAD International},
year = {2024},
volume = {17},
publisher = {Elsevier},
month = {dec},
url = {https://linkinghub.elsevier.com/retrieve/pii/S266632872400110X},
pages = {71--79},
doi = {10.1016/j.jdin.2024.06.006}
}